1. Home
  2. VHI vs EBS Comparison

VHI vs EBS Comparison

Compare VHI & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VHI

Valhi Inc.

HOLD

Current Price

$15.81

Market Cap

417.5M

Sector

Industrials

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$4.62

Market Cap

413.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHI
EBS
Founded
1932
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
417.5M
413.3M
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
VHI
EBS
Price
$15.81
$4.62
Analyst Decision
Sell
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$12.00
AVG Volume (30 Days)
10.0K
1.2M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
2.19%
N/A
EPS Growth
N/A
125.83
EPS
0.85
N/A
Revenue
$2,077,000,000.00
$742,900,000.00
Revenue This Year
$33.32
$1.29
Revenue Next Year
N/A
N/A
P/E Ratio
$19.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.44
$4.36
52 Week High
$17.67
$14.06

Technical Indicators

Market Signals
Indicator
VHI
EBS
Relative Strength Index (RSI) 65.90 23.06
Support Level $12.30 $4.36
Resistance Level $17.20 $8.73
Average True Range (ATR) 0.82 0.32
MACD 0.18 -0.16
Stochastic Oscillator 79.83 7.49

Price Performance

Historical Comparison
VHI
EBS

About VHI Valhi Inc.

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: